Collectively, these findings position mitophagy as a promising therapeutic axis for fine-tuning NLRP3-driven inflammation across diverse pathological contexts, including sepsis and neurodegenerative diseases 20, 25, 26. The gene discussed is NLRP3; the disease is Sepsis.